Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Open S1925 EVOLVE CLL 12/14/2020 42%
    Open S2007 Sacituzumab Govitecan for HER2-Neg Breast Cancer and Brain Metastases 12/15/2020 55%
    Open S1900E LUNGMAP S1900E: KRAS Targeted Therapy Sub-Study 4/2/2021 97%
    Open S1937 A Phase III Randomized Trial of Eribulin (NSC #707389) with Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for,… 2/16/2021 16%
    Open S1918 Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL 3/19/2021 24%
    Open S2005 A Phase II Randomized Study of Ibrutinib and Rituximab with or without Venetoclax in Previously Untreated Waldenstrom's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) 6/24/2021 3%
    Open S1912CD CREDIT 7/26/2021 73%
    Open S2013 I-CHECKIT 8/16/2021 100%
    Open S2104 A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors 10/14/2021 29%
    Open S2012 II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab in Patients with Poorly Differentiated Extrapulmonary Small Cell NEC 12/2/2021 24%
    Open S2107 Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable… 6/6/2022 76%
    Open S2108CD Genomic tumor board study 8/22/2022 85%
    Open S2200 S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2 9/19/2022 8%
    Open S2101 BiCaZO - iMATCH pilot 10/14/2022 17%
    Open S2010 ASPEN 1/17/2023 57%
    Open S2302 PRAGMATICA - LUNG 3/6/2023 68%
    Open S2114 Ph II consolidation therapy following CD19 CAR-T for R/R DLBCL or Gr III FL 2/23/2023 12%
    Open EAY191-S3 ComboMATCH S3 3/6/2023 3%
    Open S2205 ICE COMPRESS 3/16/2023 18%
    Open S1900G Comparing Combinations of Targeted Drugs for Advanced NSCLC that has EGFR and MET Gene Changes 4/3/2023 17%
    Scroll Table